Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).

Kunadian V, Chan D, Ali H, Wilkinson N, Howe N, McColl E, Thornton J, von Wilamowitz-Moellendorff A, Holstein EM, Burns G, Fisher A, Stocken D, De Soyza A; APPLE COPD-ICON2 Trial Investigators.

BMJ Open. 2018 May 26;8(5):e020713. doi: 10.1136/bmjopen-2017-020713.

2.

Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT.

Pickard R, Chadwick T, Oluboyede Y, Brennand C, von Wilamowitz-Moellendorff A, McClurg D, Wilkinson J, Ternent L, Fisher H, Walton K, McColl E, Vale L, Wood R, Abdel-Fattah M, Hilton P, Fader M, Harrison S, Larcombe J, Little P, Timoney A, N'Dow J, Armstrong H, Morris N, Walker K, Thiruchelvam N.

Health Technol Assess. 2018 May;22(24):1-102. doi: 10.3310/hta22240.

3.

Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trial.

Brennand C, von Wilamowitz-Moellendorff A, Dunn S, Wilkinson J, Chadwick T, Ternent L, Oluboyede Y, Wood R, Walton K, Fader M, N'Dow J, Abdel-Fattah M, McClurg D, Little P, Hilton P, Timoney A, Morris N, Thiruchelvam N, Larcombe J, Harrison S, Armstrong H, McColl E, Pickard R.

Trials. 2016 Jun 4;17(1):276. doi: 10.1186/s13063-016-1389-y.

4.

Effects of formoterol or salmeterol on impulse oscillometry in patients with persistent asthma.

Manoharan A, von Wilamowitz-Moellendorff A, Morrison A, Lipworth BJ.

J Allergy Clin Immunol. 2016 Mar;137(3):727-33.e1. doi: 10.1016/j.jaci.2015.06.012. Epub 2015 Jul 26.

5.

Structural basis for the recruitment of glycogen synthase by glycogenin.

Zeqiraj E, Tang X, Hunter RW, García-Rocha M, Judd A, Deak M, von Wilamowitz-Moellendorff A, Kurinov I, Guinovart JJ, Tyers M, Sakamoto K, Sicheri F.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):E2831-40. doi: 10.1073/pnas.1402926111. Epub 2014 Jun 30.

6.

Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis.

von Wilamowitz-Moellendorff A, Hunter RW, García-Rocha M, Kang L, López-Soldado I, Lantier L, Patel K, Peggie MW, Martínez-Pons C, Voss M, Calbó J, Cohen PT, Wasserman DH, Guinovart JJ, Sakamoto K.

Diabetes. 2013 Dec;62(12):4070-82. doi: 10.2337/db13-0880. Epub 2013 Aug 29.

7.

A noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition.

Wan M, Leavens KF, Hunter RW, Koren S, von Wilamowitz-Moellendorff A, Lu M, Satapati S, Chu Q, Sakamoto K, Burgess SC, Birnbaum MJ.

Cell Metab. 2013 Jul 2;18(1):99-105. doi: 10.1016/j.cmet.2013.06.001.

8.

AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase.

Bultot L, Guigas B, Von Wilamowitz-Moellendorff A, Maisin L, Vertommen D, Hussain N, Beullens M, Guinovart JJ, Foretz M, Viollet B, Sakamoto K, Hue L, Rider MH.

Biochem J. 2012 Apr 1;443(1):193-203. doi: 10.1042/BJ20112026.

PMID:
22233421

Supplemental Content

Loading ...
Support Center